Literature DB >> 27761382

Role of podoplanin expression in deciding the invasive potential of ameloblastoma - A retrospective IHC study.

Sindhu M Ganvir1, Pratima G Khobragade1, Swati A Bamane1, Ramnivas Kumavat1, Amit Dalmia1.   

Abstract

BACKGROUND: The aim of this study was to investigate the podoplanin expression in epithelial odontogenic tumors both non-aggressive and aggressive, tumors with and without ectomesenchyme and remnants of the odontogenic epithelium from dental follicles (DF) of unerupted teeth and to examine its role in progression and invasion of tumors.
METHOD: Thirty paraffin embedded specimens AM (15 were non-aggressive ameloblastomas and 15 ameloblastoma showing aggressive behavior), 15 paraffin embedded specimens of AOT, 15 paraffin embedded specimens of CEOT, 15 paraffin embedded specimens of CCOT were obtained and were analyzed by immunohistochemistry using anti-human podoplanin. Podoplanin expression in odontogenic epithelial cells was evaluated using a scoring method, along with calculation of the percentage of positive odontogenic cells.
RESULTS: Podoplanin was expressed strongly at the invasive front (in the peripheral odontogenic epithelial cells) of most tumors and dental follicles. Membranous expression of podoplanin in ameloblastomas was stronger in cases of ameloblastomas showing aggressive behavior than (NA) non-aggressive ameloblastomas.
CONCLUSION: Expression of podoplanin at the invasive front (in peripheral cells) of odontogenic tumors considered to be associated with neoplastic odontogenic tissues. This molecule might play a role in progression and local invasion of odontogenic tumors. The migration and invasion mediated by podoplanin in odontogenic tumors could be related to cytoskeletal reorganization.

Entities:  

Keywords:  Adenomatoid odontogenic tumor (AOT); Ameloblastoma (AM); Calcifying cystic odontogenic tumor (CCOT); Calcifying epithelial odontogenic tumor (CEOT); Dental follicle (DF); Non-aggressive ameloblastoma (NA)

Year:  2016        PMID: 27761382      PMCID: PMC5065002          DOI: 10.1016/j.jobcr.2016.07.001

Source DB:  PubMed          Journal:  J Oral Biol Craniofac Res        ISSN: 2212-4268


  22 in total

1.  A contribution to the diagnosis of the small dentigerous cyst or the paradental cyst.

Authors:  J H Damante; R N Fleury
Journal:  Pesqui Odontol Bras       Date:  2001 Jul-Sep

Review 2.  Molecular pathology of odontogenic tumors.

Authors:  H Kumamoto
Journal:  J Oral Pathol Med       Date:  2006-02       Impact factor: 4.253

3.  Podoplanin expression in human tooth germ tissues and cystic odontogenic lesions: an immunohistochemical study.

Authors:  Jozef Zustin; Hanna A Scheuer; Reinhard E Friedrich
Journal:  J Oral Pathol Med       Date:  2010-01       Impact factor: 4.253

4.  Is podoplanin expression associated with the proliferative activity of ameloblastomas?

Authors:  K C Tjioe; D T Oliveira; C T Soares; J R P Lauris; J H Damante
Journal:  Oral Dis       Date:  2012-03-23       Impact factor: 3.511

5.  Overexpression of podoplanin in oral cancer and its association with poor clinical outcome.

Authors:  Ping Yuan; Stephane Temam; Adel El-Naggar; Xian Zhou; Diane D Liu; J Jack Lee; Li Mao
Journal:  Cancer       Date:  2006-08-01       Impact factor: 6.860

6.  Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma.

Authors:  F Sandra; T Mitsuyasu; N Nakamura; Y Shiratsuchi; M Ohishi
Journal:  Oral Oncol       Date:  2001-02       Impact factor: 5.337

7.  Immunohistochemical examination for the distribution of podoplanin-expressing cells in developing mouse molar tooth germs.

Authors:  Yuri Imaizumi; Ikuko Amano; Eichi Tsuruga; Hiroshi Kojima; Yoshihiko Sawa
Journal:  Acta Histochem Cytochem       Date:  2010-10-15       Impact factor: 1.938

8.  Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray.

Authors:  K Heikinheimo; K J Jee; T Niini; Y Aalto; R-P Happonen; I Leivo; S Knuutila
Journal:  J Dent Res       Date:  2002-08       Impact factor: 6.116

9.  T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema.

Authors:  Vivien Schacht; Maria I Ramirez; Young-Kwon Hong; Satoshi Hirakawa; Dian Feng; Natasha Harvey; Mary Williams; Ann M Dvorak; Harold F Dvorak; Guillermo Oliver; Michael Detmar
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

10.  Significance of podoplanin expression in keratocystic odontogenic tumor.

Authors:  Eri Okamoto; Kentaro Kikuchi; Yuji Miyazaki; Patricia González-Alva; Yuka Oku; Akio Tanaka; Noriaki Yoshida; Masahiro Fujinami; Fumio Ide; Hideaki Sakashita; Kaoru Kusama
Journal:  J Oral Pathol Med       Date:  2009-11-18       Impact factor: 4.253

View more
  2 in total

1.  Expression of CD34, VEGFR3 and eosinophil density in selected odontogenic tumors- a pilot study.

Authors:  MohammadSina ArabSheibani; Safoura Seifi; Jahanshah Salehinejad; Ali Bijani
Journal:  J Oral Biol Craniofac Res       Date:  2019-10-03

Review 2.  New diagnostic molecular markers and biomarkers in odontogenic tumors.

Authors:  Alieh Farshbaf; Reza Zare; Farnaz Mohajertehran; Nooshin Mohtasham
Journal:  Mol Biol Rep       Date:  2021-04-06       Impact factor: 2.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.